1-7 of 7
Douwe H. Biesma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

Jan J. Cornelissen, Bronno van der Holt, Gregor E. G. Verhoef, Mars B. van 't Veer, Marinus H. J. van Oers, Harry C. Schouten, Gert Ossenkoppele, Pieter Sonneveld, Johan Maertens, Marinus van Marwijk Kooy, Martijn R. Schaafsma, Pierre W. Wijermans, Douwe H. Biesma, Shulamit Wittebol, Paul J. Voogt, Joke W. Baars, Pierre Zachée, Leo F. Verdonck, Bob Löwenberg, Adriaan W. Dekker
Journal: Blood
Blood (2009) 113 (6): 1375–1382.
https://doi.org/10.1182/blood-2008-07-168625
Published: 2009
Includes: Supplemental data
Journal Articles

An Observational Post Authorization Study on the Use of Bortezomib in Multiple Myeloma Patients in The Netherlands: Results of an Interim Analysis.

Douwe H. Biesma, MD, PhD, Henk M. Lokhorst, MD PhD, Klaas van der Hem, MD PhD, Cees van der Heul, MD PhD
Journal: Blood
Blood (2007) 110 (11): 4808.
https://doi.org/10.1182/blood.V110.11.4808.4808
Published: 2007
Journal Articles

Prevalence and Characteristics of Occult Cancer in Patients with Venous Thromboembolism.

Marielle M.J. Beckers, MD, Roger E.G. Schutgens, MD, PhD, Martin H. Prins, MD, PhD, Douwe H. Biesma, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1623.
https://doi.org/10.1182/blood.V106.11.1623.1623
Published: 2005
Journal Articles

Development of Functional Haemophilus Influenzae Type B Antibodies after Vaccination of Autologous Stem Cell Transplant Recipients.

Ankie M.T. Van der Velden, MD, Anke M.E. Claessen, PhD, Heleen Van Velzen-Blad, Douwe H. Biesma, PhD, Ger T. Rijkers, PhD
Journal: Blood
Blood (2004) 104 (11): 5058.
https://doi.org/10.1182/blood.V104.11.5058.5058
Published: 2004
Journal Articles

The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients

Clinical Trials & Observations
Gert J. Ossenkoppele, Wilfried J. Graveland, Pieter Sonneveld, Simon M. G. J. Daenen, Douwe H. Biesma, Leo F. Verdonck, M. Ron Schaafsma, Petra H. M. Westveer, Godefridus J. Peters, Paul Noordhuis, Petra Muus, Dominik Selleslag, Bronnie van der Holt, Michel Delforge, Bob Löwenberg, Gregor E. G. Verhoef, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)
Journal: Blood
Blood (2004) 103 (8): 2908–2913.
https://doi.org/10.1182/blood-2003-07-2195
Published: 2004
Journal Articles

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study

Clinical Trials & Observations
Christine M. Segeren, Pieter Sonneveld, Bronno van der Holt, Edo Vellenga, Alexandra J. Croockewit, Gregor E. G. Verhoef, Jan J. Cornelissen, Martijn R. Schaafsma, Marinus H. J. van Oers, Pierre W. Wijermans, Wim E. Fibbe, Shulamit Wittebol, Harry C. Schouten, Marinus van Marwijk Kooy, Douwe H. Biesma, Joke W. Baars, Rosalyn Slater, Monique M. C. Steijaert, Ivon Buijt, Henk M. Lokhorst
Journal: Blood
Blood (2003) 101 (6): 2144–2151.
https://doi.org/10.1182/blood-2002-03-0889
Published: 2003
Journal Articles

Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened Aα-chain, alters endothelial capillary tube formation

Annemie Collen, Annemarie Maas, Teake Kooistra, Florea Lupu, Jos Grimbergen, Fred J. L. M. Haas, Douwe H. Biesma, Pieter Koolwijk, Jaap Koopman, Victor W. M. van Hinsbergh
Journal: Blood
Blood (2001) 97 (4): 973–980.
https://doi.org/10.1182/blood.V97.4.973
Published: 2001